See if a wireless thermal device can measure CSF shunt flow during daily activities and sleep
Official title: Long-Term Tracking of Fluid Dynamics in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device During Activities of Daily Living Including Sleep
Run by Rhaeos, Inc. · NCT07050628 · Data updated 2026-11-12
A wireless thermal device is being tested to see if it can non-invasively monitor CSF shunt flow in people with hydrocephalus during everyday activities and sleep.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years and up |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | Rhaeos, Inc. Industry-sponsored |
| Locations | 2 sites (Chicago, Illinois and 1 other locations) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | August 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07050628 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and young adults aged 5 to under 22 years with an existing ventricular CSF shunt and palpable shunt over the clavicle suitable for device placement.
✕Probably not a fit
Individuals without a clearly palpable shunt or with exclusion criteria (e.g., depth >4 mm at measurement site) may not benefit from this device.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests a wireless thermal anisotropy measurement device designed to non-invasively monitor cerebrospinal fluid (CSF) shunt flow. Participants with existing ventricular shunts will wear the device while going about daily activities and sleeping, with measurements taken over multiple sessions. Cohort A includes participants with stable shunt history and no recent revisions, while Cohort B includes those with a recent shunt revision and expected discharge within a few days. Safety, feasibility, and data quality will be assessed to determine if the device can reliably reflect shunt flow in real-life conditions.
Why it matters
Potential benefit: If successful, the device could provide a non-invasive way to monitor shunt function in real time and potentially reduce the need for invasive checks.
How similar studies have gone: Prior approaches using non-invasive thermal or sensing methods have shown promise in similar shunt-monitoring contexts but this exact device and protocol are novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Existing ventricular CSF shunt 2. (Cohort A) A history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure 3. (Cohort B) A shunt revision in the previous 7 days and the investigator judges that the patient will likely be discharged within 4 days of the enrollment date 4. Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device 5. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes) 6. Subject is at least 5 years old but \< 22 years old Exclusion Criteria: 1. Shunt is not palpable or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation 2. Presence of an interfering open wound or edema in the study device measurement region 3. Subject-reported history of serious adverse skin reactions to silicone-based adhesives 4. Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable 5. Investigator judges that the subject is unlikely to successfully take reliable measurements at home 6. Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance 7. Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject 8. Prior enrollment in this study 9. Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study
Where it's running
-
Rhaeos Inc.
Chicago, Illinois, United States Recruiting -
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States Recruiting
Study contacts
- Study coordinator: Richard C Webb, PhD
- Email: cwebb@rhaeos.com
- Phone: 855-814-3569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wearable sensor to detect CSF flow in shunt tubing
This will test a small, wireless skin sensor to see if it can detect cerebrospinal fluid (CSF) flow through implanted shunts in children and adults with stable hydrocephalus.
-
CSF lactate and other biomarkers in patients with an external ventricular drain after acute brain injury
This project will test whether changes in cerebrospinal fluid lactate and other blood/CSF biomarkers can help detect ventriculostomy-associated infection in adults with acute brain injury who have an external ventricular drain.
-
Evaluating a device for measuring cerebrospinal fluid flow and headaches
This study is testing a new device that measures the flow of cerebrospinal fluid in people with hydrocephalus to see if it can help understand their headaches better.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Light therapy for severe neonatal brain bleeding
This study is testing if a special light therapy can help newborns with severe brain bleeding feel better and develop normally over time.
-
Evaluating outcomes in neurosurgery using standardized measures
This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.